Navigation Links
NW Bio Reaches 25 Clinical Trial Sites Open and Recruiting By the End of Q4, 2011
Date:1/9/2012

BETHESDA, Md., Jan. 9, 2012 /PRNewswire/ -- Northwest Biotherapeutics (OTC.BB: NWBO) (NW Bio) today announced that it successfully met its projection that it would have 25 trial sites open and recruiting by the end of Q4, 2011, in its ongoing clinical trial of DCVax® immune therapy for Glioblastoma multiforme (GBM), the most lethal form of brain cancer.  The Company likewise met or exceeded the projections it had set for the two preceding quarters (Q2 and Q3, 2011), as previously announced.

(Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO)

The Company plans to continue adding clinical trial sites, and expects to have at least 30 sites open and enrolling by the end of Q1, 2012.  The Company will also continue pursuing its programs in Europe.  The open and active trial sites are listed on the U.S. Government's website, www.clinicaltrials.gov, and on NW Bio's website, www.nwbio.com 

As previously stated, the Company's steady progress continues to reflect the growing interest from both physicians and patients, and a growing awareness of the positive data from the Company's prior clinical trials for GBM brain cancer.  In those trials, patients who received DCVax® showed a median survival of 3 years compared with median survival of 14.6 months for patients who received standard of care (surgery, radiation and chemotherapy).  Patients who received DCVax® also experienced a substantially longer time to tumor recurrence: a median of 2 years, compared with 6.9 months in patients who received standard of care.  DCVax® was well-tolerated, with no toxic side effects.

Linda Powers, CEO of NW Bio, commented that, "It is exciting to see the strong and growing interest from an ever widening ar
'/>"/>

SOURCE Northwest Biotherapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. NephroGenex Reaches Agreement with the FDA on a Subpart H Phase 3 Program for Pyridorin™
2. Proactive Brain Health Critical as Americans Life Expectancy Reaches All Time High
3. Aperion Biologics Reaches Midpoint of Enrollment in Z-Lig™ Anterior Cruciate Ligament Reconstruction Medical Device Performance Trial
4. Rules-Based Medicine Reaches a Significant Milestone in Companion Diagnostic Program With Roche
5. Biomerix Corporation Reaches European Distribution Agreement with Cellon S.A.
6. Dynamic Ventures Corp. Reaches An Agreement in Principle with NOVA Home Loans
7. BioSoteria Drug Safety Newsletter Reaches Milestone
8. Oncolytics Biotech(R) Inc. Reaches Special Protocol Assessment Agreement with the FDA on Design of Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers
9. Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target
10. Campaign to Increase the Awareness and Understanding of Lou Gehrigs Disease Reaches 22 U.S. States
11. National Ergonomics Conference and Expo Reaches 94% Exhibitor Renewal Rate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 2014 Reports from CDC ... suffer from one or more chronic health conditions - ... can address some of these diseases, but may not ... sufferers face. While implanted nerve stimulation devices today offer ... nerve, which can induce side effects. , To ...
(Date:12/19/2014)... , Dec. 18, 2014  Decision Resources Group ... dental biomaterial market will grow moderately through 2023 as ... and growing awareness of dental biomaterials all spur procedure ... such as China and ... bring dental procedures within reach for a larger proportion ...
(Date:12/17/2014)... Based on the revenues gained from surgical imaging ... by four major players contributing to approximately 74% ... GE Healthcare (U.K.), Siemens AG (Germany), Philips (Netherlands), ... Copy at http://www.marketsandmarkets.com/Market-Reports/surgical-imaging-market-210534462.html , The leading ... its strong product portfolio, which includes its flagship ...
(Date:12/17/2014)... Texas (PRWEB) December 17, 2014 ... on Global Quartz Tubing industry. For an overview ... definition, classification, application, industry chain structure, industry overview, ... quartz tubing industry has witnessed rapid ... a number of acquisitions. This report mentions quartz ...
Breaking Biology Technology:Draper Wins GSK Funding for Smaller, Smarter Implantable Devices 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 3Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 2Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 3Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 42020 Quartz Tubing Market: Global Development & Forecasts Analysis Now at DeepResearchReports.com 2
... , PHILADELPHIA, Sept. 1 ERT (Nasdaq: ... Company,s President and CEO, and Keith Schneck, the Company,s Executive Vice President ... at 11:30 AM EDT on September 9, 2009 in New York ... the presentation by visiting the Company,s corporate website at http://www.ert.com ...
... , NEW YORK, Sept. 1 Women with ovarian ... diagnosis by calling 877-OV-HOPE-1 (877-684-6731), a new, free telephone ... L,Oreal Paris and its charitable partner, the Ovarian Cancer Research Fund ... counseling and education services to individuals and families affected by cancer. ...
... FORT LAUDERDALE, Fla., Sept. 1 OmniComm Systems, Inc. (OTC ... data capture (EDC) solutions for clinical trials, and ... announced today that three additional clinical research organizations ... the CRO Preferred Program. The partnership allows CROs in the ...
Cached Biology Technology:ERT to Present at Baird's 2009 Health Care Conference on September 9, 2009 2New Call Center Helps Ovarian Cancer Patients Cope With Challenges of Diagnosis 2New Call Center Helps Ovarian Cancer Patients Cope With Challenges of Diagnosis 3New Call Center Helps Ovarian Cancer Patients Cope With Challenges of Diagnosis 4OmniComm Systems Inc. Expands Its Successful CRO Preferred Program(TM) By Signing On Three New CRO Partners 2OmniComm Systems Inc. Expands Its Successful CRO Preferred Program(TM) By Signing On Three New CRO Partners 3
(Date:11/21/2014)... 19, 2014  Earlier this year Donald Spector ... and one of the most prolific inventors in the ... transmitted from Smartphones to third party agencies. Spector envisioned ... one of the earliest known patents in this area. ... the military, child care, elder care and hospital applications. ...
(Date:11/21/2014)... , Nov. 20, 2014   Atmel® Corporation ... in microcontroller (MCU) and touch technology solutions, today launched ... sensors with the widest V cc range ... temperature accuracy and faster I 2 C bus communication ... serial EEPROM memory making them ideal for consumer, industrial, ...
(Date:11/18/2014)... Md. , Nov. 17, 2014 The Parenteral ... and U.S. regulatory agencies will speak and at least seven ... Metrics Conference at the Omni Shoreham Hotel in ... pleased once again to have significant support from the regulatory ... Europe in our effort to help ...
Breaking Biology News(10 mins):Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2
... Several years ago researchers at Michigan State University (MSU) reported ... Escherichia coli , a rod-shaped bacterium commonly found in ... added a helping of citrate to its traditional diet of ... citrate in the presence of oxygen. These same biologists ...
... what you eat" is helping scientists better understand the threatened ... beaches. A study published today in the journal ... Central Florida used a technique that links chemical signatures of ... routes. They found the technique just as effective as expensive ...
... is available in Spanish . Tried-and-true ... to studies conducted by U.S. Department of Agriculture (USDA) scientists. ... reflectance spectroscopy has been used as a rapid and nondestructive ... grains. Now Agricultural Research Service (ARS) research leader Dan Long ...
Cached Biology News:Bacteria's key innovation helps understand evolution 2New turtle tracking technique may aid efforts to save loggerhead 2New uses for old tools could boost biodiesel output 2
...
... Neogens enzyme-linked immunosorbent assay (ELISA) test ... screening devices for the detection of drugs ... kits are intended for forensic use only. ... be confirmed by a quantitative method such ...
96 Well Base Plate...
... Ambion's RNase Inhibitor is a recombinant human protein ... inhibitor of neutral pancreatic RNase A type enzymes. ... inhibitor tightly binds RNases in a 1:1 ratio. ... present in many tissues and cell types. Addition ...
Biology Products: